Skip to main content
. 2021 May 28;8:647023. doi: 10.3389/fmed.2021.647023

Table 4.

Composition and (unadjusted) mortality of HA-AKI and CA-AKI for different stages of kidney disease.

Composition Mortality
HA-AKI CA-AKI HA-AKI CA-AKI p
(n = 308) (n = 295) (n = 308) (n = 295)
Stage 1 145 (47.1%) 113 (38.3%) 28 (19.3%) 14 (12.4%) 0.135
Stage 2 57 (18.5%) 73 (24.7%) 19 (33.3%) 8 (11.0%) 0.002
Stage 3 106 (34.4%) 109 (37.0%) 50 (47.2%) 40 (36.7%) 0.120

p values indicate difference between HA-AKI and CA-AKI for mortality. Bold values indicate a significant p value.